詳細信息
- ;假單胞菌酸;
- Mupirocin
- ;Mupirocin [USAN:INN:BAN];(E)-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid;8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat;BRL 4910A;Bactroban;Centany;Mupirocina;Mupirocina [Spanish];Mupirocine;Mupirocine [French];Mupirocinum;Mupirocinum [Latin];Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-;Plasimine;Pseudomonic acid;Pseudomonic acid A;UNII-D0GX863OA5;9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl}oxy)nonanoic acid (non-preferred name);
- InChI=1/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1
- 1.183g/cm3
- 672.3°C at 760 mmHg
- 216.5°C
CAS登錄號:12650-69-0英文名字:mupirocin 英文別名:5,9-anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2e,8[2s,3s(1s,2s)]]-l-talonon-2-enonic 分子式:C26H44O9 分子量：500.62 質(zhì)量標準：USP34含量：92%-102%理化性質(zhì)：本品為白色結(jié)晶粉末，熔點77～78℃。[α]D20-19.3°(C=1，甲醇)。UV最大吸收(乙醇)：222nm(ε14500)。熔點：77-78℃溶解度：H2O: 12 mg/mL, soluble用途：局部用抗生素。通過可逆地結(jié)合于異亮氨酸轉(zhuǎn)移RNA合成酶，阻止異亮氨酸參人，從而使細胞內(nèi)含異亮氨酸的所有蛋白質(zhì)的合成停止。用于急性原發(fā)性皮膚細菌感染，如毛囊炎、膿皰病。也適用于各種細菌性皮膚感染，主要用于革蘭氏陽性球菌引起的皮膚感染，例如：膿皰病、癤腫、毛囊炎等原發(fā)性皮膚感染，及濕疹合并感染，潰瘍合并感染，創(chuàng)傷合并感染等繼發(fā)性皮膚感染。包裝：克裝/1KG/鋁箔袋
免責聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實性、準確性和合法性由發(fā)布企業(yè)負責，化工網(wǎng)對此不承擔任何保證責任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。